Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001).

Furst DE, Keystone EC, Breedveld FC, Kalden JR, Smolen JS, Antoni CE, Burmester GR, Crofford LJ, Kavanaugh A
Ann Rheum Dis. 2001 60 Suppl 3: iii2-5

PMID: 11890647 · PMCID: PMC1766671 · DOI:10.1136/ard.60.90003.iii2

MeSH Terms (15)

Antibodies, Monoclonal Antirheumatic Agents Arthritis, Rheumatoid Contraindications Controlled Clinical Trials as Topic Female Humans Male Meta-Analysis as Topic Methotrexate Pregnancy Randomized Controlled Trials as Topic Recombinant Fusion Proteins Rheumatic Diseases Tumor Necrosis Factor-alpha

Connections (1)

This publication is referenced by other Labnodes entities: